Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
University of California, San Francisco
Stanford University
University of California, San Francisco
Children's Oncology Group
University of Michigan Rogel Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Northwestern University
Mayo Clinic
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Mayo Clinic
City of Hope Medical Center
Mayo Clinic
Jonsson Comprehensive Cancer Center
University of California, San Francisco
City of Hope Medical Center
University of Miami
National Cancer Institute (NCI)
University of California, San Francisco
Mayo Clinic
Stanford University
Northwestern University
Stanford University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)